Subscribe To
Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million
Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction cash of approximately $170 million expected to fund operations into 2026 Funds multiple potentially value-creating milestones, including advancing its lead product candidate in Alpha-1 antitrypsin deficiency (AATD) through a clinical trial Shares to trade on Nasdaq under the ticker “KRRO” […] The post Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Mi...
Read More
Posted: Nov 3 2023, 16:19
Author Name: forextv
Views: 112236